Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

Merck
Mallinckrodt
Moodys
Colorcon
Baxter
McKesson

Last Updated: May 26, 2022

CLINICAL TRIALS PROFILE FOR LUVERIS


✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Luveris

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00328926 ↗ LuverisĀ® (Lutropin Alfa for Injection) in Women With Hypogonadotropic Hypogonadism (Luteinizing Hormone [LH] Less Than [<] 1.2 International Unit Per Liter [IU/L]) Terminated EMD Serono Phase 4 2006-03-01 Sponsor has decided to discontinue LuverisĀ® in the United States (US) due to level of customer demand for this product, and not due to any efficacy or safety concerns.
NCT00439829 ↗ Synchronization of Follicle Wave Emergence and Ovarian Stimulation Completed Royal University Hospital Foundation Phase 4 2007-02-01 The objective of the study is to elucidate the effect of synchronizing initiation of ovarian stimulation treatment with follicular wave emergence in poor responder patients undergoing IVF/ICSI and ET. We hypothesize that initiating treatment on day 1 versus day 4 of the cycle will increase the number of follicles recruited and oocytes retrieved.
NCT00439829 ↗ Synchronization of Follicle Wave Emergence and Ovarian Stimulation Completed University of Saskatchewan Phase 4 2007-02-01 The objective of the study is to elucidate the effect of synchronizing initiation of ovarian stimulation treatment with follicular wave emergence in poor responder patients undergoing IVF/ICSI and ET. We hypothesize that initiating treatment on day 1 versus day 4 of the cycle will increase the number of follicles recruited and oocytes retrieved.
NCT00553293 ↗ Nordic Luveris Study Completed Helse Fonna Phase 4 2003-08-01 To study whether addition of human LH hormone (Luveris) during the final days of stimulation with recombinant FSH (Gonal-f) for controlled ovarian stimulation will be of benefit for patients undergoing in vitro fertilisation.
NCT00553293 ↗ Nordic Luveris Study Completed Herlev Hospital Phase 4 2003-08-01 To study whether addition of human LH hormone (Luveris) during the final days of stimulation with recombinant FSH (Gonal-f) for controlled ovarian stimulation will be of benefit for patients undergoing in vitro fertilisation.
NCT00553293 ↗ Nordic Luveris Study Completed Holbaek Sygehus Phase 4 2003-08-01 To study whether addition of human LH hormone (Luveris) during the final days of stimulation with recombinant FSH (Gonal-f) for controlled ovarian stimulation will be of benefit for patients undergoing in vitro fertilisation.
NCT00553293 ↗ Nordic Luveris Study Completed Hvidovre University Hospital Phase 4 2003-08-01 To study whether addition of human LH hormone (Luveris) during the final days of stimulation with recombinant FSH (Gonal-f) for controlled ovarian stimulation will be of benefit for patients undergoing in vitro fertilisation.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Luveris

Condition Name

Condition Name for Luveris
Intervention Trials
Infertility 11
Ovulation Induction 3
Ovarian Stimulation 2
Sleep Restriction 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Luveris
Intervention Trials
Infertility 16
Hypogonadism 4
Infertility, Female 3
Obesity 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Luveris

Trials by Country

Trials by Country for Luveris
Location Trials
United States 6
Spain 4
China 3
Italy 2
Canada 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Luveris
Location Trials
California 2
New Jersey 2
Colorado 1
Massachusetts 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Luveris

Clinical Trial Phase

Clinical Trial Phase for Luveris
Clinical Trial Phase Trials
Phase 4 8
Phase 3 5
Phase 2 6
[disabled in preview] 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Luveris
Clinical Trial Phase Trials
Completed 11
Terminated 6
Unknown status 3
[disabled in preview] 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Luveris

Sponsor Name

Sponsor Name for Luveris
Sponsor Trials
Merck KGaA 7
Merck KGaA, Darmstadt, Germany 7
EMD Serono 3
[disabled in preview] 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Luveris
Sponsor Trials
Other 33
Industry 23
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Harvard Business School
McKesson
Medtronic
Boehringer Ingelheim
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.